Cite
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry.
MLA
Nowatzke, Joseph, et al. “Coronary Artery Disease and Revascularization Associated with Immune Checkpoint Blocker Myocarditis: Report from an International Registry.” European Journal of Cancer, vol. 177, Dec. 2022, pp. 197–205. EBSCOhost, https://doi.org/10.1016/j.ejca.2022.07.018.
APA
Nowatzke, J., Guedeney, P., Palaskas, N., Lehmann, L., Ederhy, S., Zhu, H., Cautela, J., Francis, S., Courand, P.-Y., Deswal, A., Ewer, S. M., Aras, M., Arangalage, D., Ghafourian, K., Fenioux, C., Finke, D., Peretto, G., Zaha, V., Itzhaki Ben Zadok, O., & Tajiri, K. (2022). Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry. European Journal of Cancer, 177, 197–205. https://doi.org/10.1016/j.ejca.2022.07.018
Chicago
Nowatzke, Joseph, Paul Guedeney, Nicholas Palaskas, Lorenz Lehmann, Stephane Ederhy, Han Zhu, Jennifer Cautela, et al. 2022. “Coronary Artery Disease and Revascularization Associated with Immune Checkpoint Blocker Myocarditis: Report from an International Registry.” European Journal of Cancer 177 (December): 197–205. doi:10.1016/j.ejca.2022.07.018.